rs1453983744
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001005242.3(PKP2):c.1379-2A>T variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000248 in 1,611,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001005242.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- arrhythmogenic right ventricular dysplasia 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- dilated cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151920Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249604 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460046Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726484 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74192 show subpopulations
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Pathogenic:3
The PKP2 c.1511-2A>T variant (rs1453983744), to our knowledge, is not reported in the medical literature, but another variant at this nucleotide has been identified in an individual with arrhythmogenic right ventricular dysplasia/cardiomyopathy and was shown to alter splicing (Groeneweg 2014). The identified variant is reported in ClinVar (Variation ID: 518485) and is found in the general population with an allele frequency of 0.0004% (1/249,604 alleles) in the Genome Aggregation Database. This variant abolishes the canonical splice acceptor site of intron 6, which is likely to disrupt gene function. Based on available information, this variant is considered to be pathogenic. -
- -
This sequence change affects an acceptor splice site in intron 6 of the PKP2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (no rsID available, gnomAD 0.007%). Disruption of this splice site has been observed in individuals with arrhythmogenic right ventricular cardiomyopathy (PMID: 25087486, 38336791). ClinVar contains an entry for this variant (Variation ID: 518485). Studies have shown that disruption of this splice site results in skipping of exon 7, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 25087486). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype Pathogenic:1
The c.1511-2A>T intronic pathogenic mutation results from an A to T substitution two nucleotides upstream from coding exon 7 in the PKP2 gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. In addition, another alteration impacting the same acceptor site c.1511-2A>G, has been detected in an individual with arrhythmogenic right ventricular cardiomyopathy (ARVC) and shown to result in skipping of exon 7 with a consequent shift in the reading frame (Groeneweg JA et al. Heart Rhythm. 2014;11:2010-7). Based on the supporting evidence, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at